To address the clinical relevance of our in vitro mechanistic data, we assayed expression of ATF4, XBP-1 and HO-1 in clinical samples obtained from patients with cutaneous leishmaniasis. This evidence concerns the gene ATF4 and cutaneous leishmaniasis.